Expression of drug targets in patients treated with sorafenib, carboplatin and paclitaxel.

PLoS One · 2013 · PMC3735539 · PMID 23936348

Europe PMC DOI

hedged sentences

0.0800

closest p · 1.6× alpha

0.2700

boldest claim

The sentences

a trend toward significanceP = 0.08so close (0.05 < p ≤ 0.1)

A trend toward significance was seen for FGF-R1 ( P = 0.08).

also in 3,729 other papers

did not reach statistical significanceP = 0.27not close (p > 0.1)

Although expression of ERK1/2 was slightly lower in patients who achieved a clinical response, this association did not reach statistical significance ( P = 0.27).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.